276 related articles for article (PubMed ID: 18840002)
21. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis.
Imperiale TF; Birgisson S
Ann Intern Med; 1997 Dec; 127(12):1062-71. PubMed ID: 9412308
[TBL] [Abstract][Full Text] [Related]
22. Pharmacologic therapy for nonvariceal upper gastrointestinal bleeding.
Wu JC; Sung JJ
Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):671-9. PubMed ID: 21944417
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
[TBL] [Abstract][Full Text] [Related]
24. Drugs for pH control in upper gastrointestinal bleeding.
Brunner G; Luna P; Thiesemann C
Aliment Pharmacol Ther; 1995; 9 Suppl 1():47-50. PubMed ID: 7495943
[TBL] [Abstract][Full Text] [Related]
25. Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding.
Mohamed SA; al Karawi MA
Hepatogastroenterology; 1996; 43(10):863-5. PubMed ID: 8884305
[TBL] [Abstract][Full Text] [Related]
26. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
Huggins RM; Scates AC; Latour JK
Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
[TBL] [Abstract][Full Text] [Related]
27. Independent risk factors of 30-day outcomes in 1264 patients with peptic ulcer bleeding in the USA: large ulcers do worse.
Camus M; Jensen DM; Kovacs TO; Jensen ME; Markovic D; Gornbein J
Aliment Pharmacol Ther; 2016 May; 43(10):1080-9. PubMed ID: 27000531
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Gralnek IM; Dumonceau JM; Kuipers EJ; Lanas A; Sanders DS; Kurien M; Rotondano G; Hucl T; Dinis-Ribeiro M; Marmo R; Racz I; Arezzo A; Hoffmann RT; Lesur G; de Franchis R; Aabakken L; Veitch A; Radaelli F; Salgueiro P; Cardoso R; Maia L; Zullo A; Cipolletta L; Hassan C
Endoscopy; 2015 Oct; 47(10):a1-46. PubMed ID: 26417980
[TBL] [Abstract][Full Text] [Related]
29. Management of bleeding peptic ulcer: current status of intravenous proton pump inhibitors.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():7-12. PubMed ID: 15588788
[TBL] [Abstract][Full Text] [Related]
30. [Intravenous gastric acid inhibition for stress ulcers and bleeding peptic ulcers].
Geus WP; Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2514-8. PubMed ID: 10627753
[TBL] [Abstract][Full Text] [Related]
31. The role of intravenous proton pump inhibitors in the modern management of nonvariceal upper gastrointestinal bleeding.
Barkun AN
Drugs Today (Barc); 2003 Mar; 39 Suppl A():3-10. PubMed ID: 12712215
[TBL] [Abstract][Full Text] [Related]
32. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
Martin RA
Conn Med; 2004 Aug; 68(7):435-8. PubMed ID: 15384242
[TBL] [Abstract][Full Text] [Related]
33. Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation.
Ojiako K; Shingala H; Schorr C; Gerber DR
Am J Crit Care; 2008 Mar; 17(2):142-7. PubMed ID: 18310651
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and therapeutic approach to upper gastrointestinal bleeding.
Poddar U
Paediatr Int Child Health; 2019 Feb; 39(1):18-22. PubMed ID: 30058470
[TBL] [Abstract][Full Text] [Related]
35. Gastric acid inhibition in the treatment of peptic ulcer hemorrhage.
Ghassemi KA; Kovacs TO; Jensen DM
Curr Gastroenterol Rep; 2009 Dec; 11(6):462-9. PubMed ID: 19903422
[TBL] [Abstract][Full Text] [Related]
36. High-dose pre-endoscopic intravenous proton pump inhibitors in upper gastrointestinal bleeding: Utility or futility?
Primignani M; Tosetti G
Dig Liver Dis; 2021 Mar; 53(3):387-388. PubMed ID: 33414085
[No Abstract] [Full Text] [Related]
37. Treatment of nonvariceal upper gastrointestinal bleeding.
Rivkin K; Lyakhovetskiy A
Am J Health Syst Pharm; 2005 Jun; 62(11):1159-70. PubMed ID: 15914876
[TBL] [Abstract][Full Text] [Related]
38. Reply to: High-dose pre-endoscopic intravenous proton pump inhibitors in upper gastrointestinal bleeding: utility or futility?
Marmo R; Soncini M; Bucci C; Zullo A
Dig Liver Dis; 2021 Mar; 53(3):389. PubMed ID: 33472768
[No Abstract] [Full Text] [Related]
39. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials.
Yang Z; Wu Q; Liu Z; Wu K; Fan D
Digestion; 2011; 84(4):315-20. PubMed ID: 22075541
[TBL] [Abstract][Full Text] [Related]
40. Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding.
Barkun AN; Cockeram AW; Plourde V; Fedorak RN
Aliment Pharmacol Ther; 1999 Dec; 13(12):1565-84. PubMed ID: 10594391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
